Affinity Asset Advisors »

Kezar Life Sciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Kezar Life Sciences (KZR) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Kezar Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Kezar Life Sciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kezar Life Sciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4M 229k 6.29
2024-12-31 $956k 142k 6.72

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Kezar Life Sciences

BML Capital Management
Suvretta Capital Management
Tang Capital Management
Vanguard Group
Nantahala Capital Management
Affinity Asset Advisors
OrbiMed Advisors
Stonepine Capital Management
Renaissance Technologies
Peapod Lane Capital
Acadian Asset Management
Susquehanna International
ADAR1 Capital Management
Ikarian Capital
BlackRock

View all funds holding Kezar Life Sciences